|
Early Detection Reserarch Network (EDRN): Biomarker Reference Laboratory
|
Y01CN000001-
|
$598,849
|
$598,849
|
N/A
|
N/A
|
|
JPL EDRN Cancer Research Informatics Platform
|
Y01CN005004-
|
$1,209,300
|
$1,209,300
|
N/A
|
N/A
|
|
National Death Index Services
|
Y01PC000019-
|
$65,000
|
$65,000
|
N/A
|
N/A
|
|
Breast Cancer and the Environment Research Program (BCERP)
|
Y01PC000020-
|
$125,000
|
$125,000
|
N/A
|
N/A
|
|
Post Census Estimates of Populations of US Counties
|
Y01PC000080-
|
$78,000
|
$78,000
|
N/A
|
N/A
|
|
Cancer Questions on the National Health Interview Survey
|
Y01PC009051-
|
$1,711,000
|
$1,711,000
|
N/A
|
N/A
|
|
Feasibility Study of Linkage of Cancer Registry to Multiple Healthcare Payers
|
Y01PC009083-
|
$249,885
|
$249,885
|
N/A
|
N/A
|
|
Undiagnosed Diseases Program
|
Y02CO000202-
|
$207,000
|
$207,000
|
N/A
|
N/A
|
|
National Cancer Institute support of NIH Mouse Imaging Facility (MIF)
|
Y02CO007103-
|
$465,853
|
$465,853
|
N/A
|
N/A
|
|
The Laboratory of Bioengineering and Physical Science (LBPS) support in bioengine
|
Y02CO008202-
|
$673,488
|
$673,488
|
N/A
|
N/A
|
|
A Companion Diagnostic for Prognosis of Kidney Cancer
|
N43CO100135-000
|
$199,597
|
$199,597
|
Gillespie, John
|
20/20 GENE SYSTEMS, INC.
|
|
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
|
2R44CA123994-04
|
$750,000
|
$750,000
|
Lebowitz, Michael
|
20/20 GENESYSTEMS, INC.
|
|
Novel Targeted Therapy for Breast Cancer
|
2R44CA124179-02A2
|
$575,793
|
$575,793
|
Serrero, Ginette
|
A AND G PHARMACEUTICAL, INC.
|
|
National Cancer Institute ARP Surveillance support
|
N01CA190082
|
$1,001
|
$1,001
|
N/A
|
ABT ASSOCIATES, INC.
|
|
TAS::75 0849::TAS NATIONAL TOBACCO CESSATION COLLABORATIVE (NTCC) AND THE YOUTH
|
N02CA190168
|
$100,000
|
$100,000
|
MERIWEATHER, PATRICK
|
ACADEMY FOR EDUCATIONAL DEVELOPMENT
|
|
Phase O Carboplatin Microdosing Diagnostics Trial
|
N43CO100133-000
|
$195,550
|
$195,550
|
Henderson, Paul
|
ACCELERATED MEDICAL DIAGNOSTICS, LLC
|
|
Decreasing Calories, Fat & Sodium in Restaurant Meals for Widespread Industry Ado
|
1R43CA150528-01
|
$99,989
|
$99,989
|
HILL, ESTHER
|
ACCENTS ON HEALTH, INC.
|
|
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
|
2R44CA112852-03
|
$1,083,824
|
$1,083,824
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Precisely Shaped Acoustic Ablation of Tumors Under 3D Ultrasound Image Guidance
|
3R44CA134169-03S1
|
$85,424
|
$85,424
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Precisely Shaped Acoustic Ablation of Tumors Under 3D Ultrasound Image Guidance
|
5R44CA134169-03
|
$1,000,000
|
$1,000,000
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Operation and Maintenance of the Biological Data Processing System
|
N02CM100009-000
|
$755,449
|
$755,449
|
TEKLU, YOHANESS
|
ADDIS INC:1108540
|
|
Listeria-Based Therapeutic Cancer Vaccine for Melanoma
|
1R43CA153669-01A1
|
$200,763
|
$200,763
|
Brockstedt, Dirk
|
ADURO BIOTECH
|
|
Data acquisition system for multiplex analysis of color encoded particles
|
4R42CA140109-02
|
$795,459
|
$795,459
|
Gorbovitski, Boris
|
ADVANCED BIOMEDICAL MACHINES, INC.
|
|
Automated Systems for Detection and Molecular Characterization of Circulating Tum
|
2R44CA122444-04
|
$997,818
|
$997,818
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
Clinical trials data collection during patient care using a novel technology solu
|
1R43CA150466-01A1
|
$143,112
|
$143,112
|
Clary, Gregory
|
ADVANCED DIGITAL SYSTEMS, INC.
|
|
Targeting a Poor Prognosis Marker for Tumor Therapy
|
1R43CA144614-01A1
|
$150,480
|
$150,480
|
Lappi, Douglas
|
ADVANCED TARGETING SYSTEMS, INC.
|
|
PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL EXPANSION F
|
N01CN075022-066
|
$1,291,459
|
$1,291,459
|
Fouad, Mona
|
ALABAMA UNIV BIRMINGHAM:1109410
|
|
PRECLINICAL PHARMACOLOGICAL STUDIES OF ANTITUMOR AND OTHER THERAPEUTIC AGENTS
|
N01CM522007-014
|
$25,000
|
$25,000
|
ZHANG, RUIWEN
|
ALABAMA UNIV BIRMINGHAM:1109410
|
|
Site-directed Chemotherapy for Breast Cancer using Novel Angiogenesis Inhibitor
|
5R21CA135245-02
|
$203,280
|
$203,280
|
MOUSA, SHAKER
|
ALBANY COLLEGE OF PHARMACY
|
|
Regulation of MMP-9 mRNA stability and tumor growth by alpha3 beta1 integrin
|
5R01CA129637-03
|
$325,775
|
$325,775
|
DIPERSIO, C
|
ALBANY MEDICAL COLLEGE
|
|
Mitochondrial Redox Control of Metastasis
|
1K99CA143229-01A1
|
$112,899
|
$112,899
|
Hempel, Nadine
|
ALBANY MEDICAL COLLEGE
|
|
Regulation of Tumor Cell Migration by Mitochondrial Superoxide Dismutase
|
5F32CA134165-03
|
$57,686
|
$57,686
|
Hempel, Nadine
|
ALBANY MEDICAL COLLEGE
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-17
|
$281,080
|
$281,080
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Concerted role for integrin alpha3beta1 and TGFb signaling in cancer progression
|
1F32CA153976-01
|
$50,474
|
$50,474
|
Subbaram, Sita
|
ALBANY MEDICAL COLLEGE
|
|
The Role of ATF3 in the DNA Damage Response
|
1R01CA139107-01A2
|
$262,280
|
$262,280
|
Yan, Chunhong
|
ALBANY MEDICAL COLLEGE
|
|
KLF8 Regulation of EMT Tumor Metastasis
|
5R01CA132977-02
|
$293,198
|
$293,198
|
ZHAO, JIHE
|
ALBANY MEDICAL COLLEGE
|
|
Developing Rwandan Research Capacity in Cervical Cancer and other AIDS Malignanci
|
1D43CA153793-01
|
$499,407
|
$499,407
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Identification and Classification of Epigenetic Changes in Head and Neck Cancer
|
3R21CA131648-02S1
|
$73,123
|
$73,123
|
BELBIN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Identification and Classification of Epigenetic Changes in Head and Neck Cancer
|
5R21CA131648-02
|
$182,600
|
$182,600
|
BELBIN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Old Drugs and New Strategies for Tumor Metastasis
|
5R01CA129598-03
|
$249,000
|
$249,000
|
BRESNICK, ANNE
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Persistent HPV in Women at Risk for Cervix Cancer
|
5U01CA078527-13
|
$596,586
|
$596,586
|
BURK, ROBERT
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
MOTILITY AND INVASION
|
5P01CA100324-08
|
$2,091,643
|
$2,091,643
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
MICROENVIRONMENTS OF INVASION IN HUMAN BREAST TUMORS
|
5R01CA113395-05
|
$286,106
|
$286,106
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Novel Methods for Detecting Cell Interactions in the Tumor Microenvironment
|
5U54CA126511-05
|
$377,838
|
$377,838
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Signal Transduction & Actin During Amoeboid Chemotaxis
|
9R01CA150344-22
|
$344,147
|
$344,147
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
PTEN and the molecular genetics of endometrial cancer
|
5R01CA097097-07
|
$334,341
|
$334,341
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Genetic analysis of the P13K/Akt pathway in thyroid benign and malignant disease
|
5R01CA128943-02
|
$344,450
|
$344,450
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
DNA mismatch repair and cancer in murine models
|
5R01CA076329-13
|
$394,734
|
$394,734
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
The Role of Late MMR Proteins in DNA Repair and Cancer
|
5R01CA093484-09
|
$390,363
|
$390,363
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
1R01CA148966-01
|
$832,203
|
$832,203
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
Total relevant funding to Cancer for this search: $5,098,146,876
|